Objective: To present a single case report on successful radiotherapy treatment of lacrimal gland infi ltration in patient with Sjögren΄s syndrome. Background: Radiotherapy is occassionally used for the treatment of benign disorders. There is no report on use of radiotherapy for local treatment of the Sjögren΄s syndrome in the literature. Methods: Female patient with lacrimal gland involvement as a part of Sjögren΄s syndrome with diplopia and visus deterioration was treated by radiotherapy with eye shielding. Results: Regression of the infi ltration with full restoration of visus and minimal acute radiation reaction was achieved. Conclusion: A case report of successful use of local radiotherapy in the treatment of lacrimal gland affected by Sjögren΄s syndrome is presented (Fig. 3, Ref. 6 ). Full Text in PDF www.elis.sk.
Sjögren΄s syndrome (SS) is an autoimmune disease of exocrine glands that occurs with a prevalence of 0.5 -1 %. It has a female predominance and is commonly diagnosed in the 4th -5th decades of life. It is characterized by progressive lymphocytic infi ltration of exocrine glands and epithelium at multiple sites. Involvement of the lacrimal and salivary glands eventually leads to the 2 typical features of the disease: keratoconjunctivitis sicca and xerostomia. SS may occur in 2 forms: primary, when the clinical manisfestation of the syndrome is seen alone, and secondary, when associated with another autoimmune disease, most commonly rheumatoid arthritis.
Numerous criteria have been proposed to facilitate the accurate classifi cation and diagnosis of SS. The criteria were recently revised and modifi ed by the American-European Consensus Group (1). This set of criteria includes 6 different items: ocular symptoms; oral symptoms; ocular signs; histopatologic examination of minor salivary glans; objective evidence of salivary gland involvement; and serologic evaluation of autoantibodies.
The treatment of patients with Sjögren΄s syndrome is directed toward the particular areas of the body that are involved, and toward complications, such as infection. There is no report on the use of radiotherapy for local treatment of this disease in the literature. In June 2007, the patient was examined at the Deptartment of Ophthalmology for swelling of the right lacrimal gland and keratoconjunctivitis sicca. Lubrication therapy was indicated. The lacrimal gland swelling progressed during 3 months accompanied by pains, keratoconjunctivitis, diplopia, and visus deterioration as a result of hypermetropisation caused by enlarged lacrimal gland (Fig. 1) . CT examination showed homogenous and enhanced lacrimal gland of 30 x 16 x 33 mm. Biopsy of the lacrimal gland proved focal lymphocytic infi ltration. Because of progressive lesion the patient was suggested to consider radiotherapy treatment.
Methods

Forty
The patient had signed an informed consent and radiotherapy was performed between 18th October and 12th November 2007. The right upper eyelid was irradiated by a single radiation fi eld, which was shaped by lead shielding to avoid exposition of surrounding healthy tissues. The eye was covered by leaden eye-bath located under the eyelid (Fig. 2) . Therapeutic X-ray machine with beam energy of 180 kV was used for irradiation. The dosis was 15 times 2 Gy with daily fractionation.
Results
By the end of radiotherapy the eyelid swelling and pains had resolved. The acute adverse reaction consisted of transient periocular skin erytema and conjunctive hyperemia. During the ophthalmological examination on the 29th January 2008 the patient presented without diplopia, able to read and to watch television, without lacrimal gland prominence, and with cured acute radiation reaction.
In October 2008, bilateral parotidectomy was performed because of recurrent infi ltration of the right parotid and left parotid swelling. Lagophthalmos of the right eye after surgery was solved by temporary tarzoraphy. At the last ophthamological examination in April 2010, the regression of the right eyelid infi ltration lasted, and the perimeter after radiotherapy was intact (Fig. 3) .
Discussion
The treatment of primary SS is focused on sicca features and relief of dry eyes and mouth. Systemic medicamentous treatment is based mainly on the administration of steroids, antirheumatic drugs, and immunosuppressants. It has frequent side effects and is used mainly for the treatment of extraglandular manifestations or complications. Patient with symptomatic disease progression of lacrimal gland involvement despite standard therapy was referred to our department to consider local radiotherapy.
Antiproliferative effect of radiotherapy is used not only in the treatment of malignant tumors, but also for irradiation of benign diseases including lymphoproliferative disorders like lymphoid orbital pseudotumor (2, 3, 4) or Kimura ś disease (5). The median dose used for the irradiation is about 30 Gy. There is only one paper dealing with radiotherapy of Mikulicz΄s disease to be found (6), but no other paper on the use of radiotherapy for SS has been reported up to now.
At our department we use an eye sparing radiotherapy technique for irradiation of skin cancers in the eyelid region with very satisfactory results. We are presenting a case report of successful use of this technique in the treatment of lacrimal gland affected SS.
Conclusion
We are presenting a case report of successful use of local radiotherapy in the treatment of lacrimal gland affecred by Sjögren΄s syndrome. 
